Literature DB >> 19327589

Myelodysplasia and acute leukemia as late complications of marrow failure: future prospects for leukemia prevention.

Grover C Bagby1, Gabrielle Meyers.   

Abstract

Patients who have acquired and inherited bone marrow failure syndromes are at risk for the development of clonal neoplasms including acute myeloid leukemia, myelodysplastic syndrome, and paroxysmal nocturnal hemoglobinuria. This article reviews the evidence supporting a model of clonal selection, a paradigm that provides a reasonable expectation that these often fatal complications might be prevented in the future.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19327589      PMCID： PMC2697169          DOI： 10.1016/j.hoc.2009.01.006

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  82 in total

1.  Predictive factors for cure after immunosuppressive therapy of aplastic anemia.

Authors:  R Viollier; A Tichelli
Journal:  Acta Haematol       Date:  2000       Impact factor: 2.195

2.  Foxo3a is essential for maintenance of the hematopoietic stem cell pool.

Authors:  Kana Miyamoto; Kiyomi Y Araki; Kazuhito Naka; Fumio Arai; Keiyo Takubo; Satoshi Yamazaki; Sahoko Matsuoka; Takeshi Miyamoto; Keisuke Ito; Masako Ohmura; Chen Chen; Kentaro Hosokawa; Hiromitsu Nakauchi; Keiko Nakayama; Keiichi I Nakayama; Mine Harada; Noboru Motoyama; Toshio Suda; Atsushi Hirao
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

Review 3.  Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia.

Authors:  M W Lensch; R K Rathbun; S B Olson; G R Jones; G C Bagby
Journal:  Leukemia       Date:  1999-11       Impact factor: 11.528

4.  Chromosome translocations and covert leukemic clones are generated during normal fetal development.

Authors:  Hiroshi Mori; Susan M Colman; Zhijian Xiao; Anthony M Ford; Lyn E Healy; Craig Donaldson; Jill M Hows; Cristina Navarrete; Mel Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

5.  Recent improvement in outcome of unrelated donor transplantation for aplastic anemia.

Authors:  R Viollier; G Socié; A Tichelli; A Bacigalupo; E T Korthof; J Marsh; J Cornish; P Ljungman; R Oneto; A N Békássy; M Fuehrer; S Maury; H Schrezenmeier; M T van Lint; D Wojcik; A Locasciulli; J R Passweg
Journal:  Bone Marrow Transplant       Date:  2007-11-05       Impact factor: 5.483

Review 6.  Risks and benefits of tumor necrosis factor-alpha inhibitors in the management of psoriatic arthritis: systematic review and metaanalysis of randomized controlled trials.

Authors:  Amr A Saad; Deborah P M Symmons; Peter R Noyce; Darren M Ashcroft
Journal:  J Rheumatol       Date:  2008-03-15       Impact factor: 4.666

7.  Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.

Authors:  Lukasz P Gondek; Ramon Tiu; Christine L O'Keefe; Mikkael A Sekeres; Karl S Theil; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2007-10-22       Impact factor: 22.113

8.  Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia.

Authors:  Elaine Sloand; Sonnie Kim; Jaroslaw P Maciejewski; John Tisdale; Dean Follmann; Neal S Young
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

9.  Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children.

Authors:  Seiji Kojima; Akira Ohara; Masahiro Tsuchida; Toru Kudoh; Ryoji Hanada; Yuri Okimoto; Takashi Kaneko; Toshikuni Takano; Koichiro Ikuta; Ichiro Tsukimoto
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

10.  Cancer incidence in persons with Fanconi anemia.

Authors:  Philip S Rosenberg; Mark H Greene; Blanche P Alter
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113
View more
  4 in total

Review 1.  New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

Authors:  Wendy Weston; Vineet Gupta; Rebecca Adkins; Roland Jurecic
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

2.  FANCL ubiquitinates β-catenin and enhances its nuclear function.

Authors:  Kim-Hien T Dao; Michael D Rotelli; Curtis L Petersen; Stefanie Kaech; Whitney D Nelson; Jane E Yates; Amy E Hanlon Newell; Susan B Olson; Brian J Druker; Grover C Bagby
Journal:  Blood       Date:  2012-05-31       Impact factor: 22.113

3.  Loss of ercc1 results in a time- and dose-dependent reduction of proliferating early hematopoietic progenitors.

Authors:  Judith H E Verhagen-Oldenampsen; Jurgen R Haanstra; Paulina M H van Strien; Marijke Valkhof; Ivo P Touw; Marieke von Lindern
Journal:  Anemia       Date:  2012-06-03

4.  Therapeutic targeting of NOTCH signaling ameliorates immune-mediated bone marrow failure of aplastic anemia.

Authors:  Justine E Roderick; Gabriela Gonzalez-Perez; Christina Arieta Kuksin; Anushka Dongre; Emily R Roberts; Janani Srinivasan; Chester Andrzejewski; Abdul H Fauq; Todd E Golde; Lucio Miele; Lisa M Minter
Journal:  J Exp Med       Date:  2013-06-03       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.